Sphere Medical Holding develops, manufactures and commercializes monitoring products for critical care environments. The Company offers microanalyser platforms that are used to measure clinical analytes, including pH, glucose, potassium, sodium, calcium, oxygen, Hct and carbon dioxide. Its products include analyzers for intensive care units and operating rooms, cardiopulmonary bypass monitors, monitoring catheters, intravenous anaesthetic analyzers, systems for the intermittent analysis and continuous monitoring of blood and other fluids, sensors for catheters or other measurement probes. Sphere Medical Holding's products provide healthcare professionals the information to manage therapy and optimize patient outcomes.